Johnson & Johnson settles New York opioid suit in $230 million deal

Johnson & Johnson has agreed to a $230 million settlement with New York state, resolving complaints from the state’s attorney general over the pharmaceutical company’s role in the opioid epidemic.Johnson & Johnson has agreed to a $230 million settlement with New York state, resolving complaints from the state’s attorney general over the pharmaceutical company’s role in the opioid epidemic.